Search research articles
Contact Us
Filters
Showing results (51-60 of 86) with videos related to
Page
of 9
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
July 24, 2025
Real-time continuous glucose monitoring vs self-monitoring of blood glucose in distinct multi-ethnic cohorts of patients living with insulin-treated type 2 diabetes in the United States: A cost-utility analysis from a Medicare perspective
Hamza Alshannaq, Jessica Matuoka, Richard F Pollock, et al.
BMJ Open
|
July 2, 2017
Patient safety during procedural sedation using capnography monitoring: a systematic review and meta-analysis
Rhodri Saunders, Michel M R F Struys, Richard F Pollock, et al.
Scientific Reports
|
January 18, 2024
Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO<sub>2</sub> emissions in Sweden
Lars-Olaf Cardell, Thomas Sterner, Waqas Ahmed, et al.
Patient Related Outcome Measures
|
October 4, 2023
Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China
Shanlian Hu, Depei Wu, Jing Wu, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 21, 2018
Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States
Lars Wilkinson, Barnaby Hunt, Pierre Johansen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 15, 2022
Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts
Johannes Pöhlmann, Klas Bergenheim, Juan-Jose Garcia Sanchez, et al.
Annals of Hepatology
|
February 10, 2025
Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)
Zobair M Younossi, James M Paik, Linda Henry, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2026
Cost-effectiveness analysis of Dexcom ONE+ real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with type 2 diabetes in Aotearoa New Zealand
Ryan G Paul, Jessica Y Matuoka, Hamza A Alshannaq, et al.
Patient Related Outcome Measures
|
June 24, 2024
Systematic Literature Review of Studies Reporting Measures of Functional Outcome or Quality of Life in People with Negative Symptoms of Schizophrenia
Dusica Hadzi Boskovic, Jayne Smith-Palmer, Johannes Pöhlmann, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
June 17, 2024
Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden
Lars-Olaf Cardell, Thomas Sterner, Waqas Ahmed, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 86) with videos related to
Sort By:
Page
of 9
Journal of Managed Care & Specialty Pharmacy
|
July 24, 2025
Real-time continuous glucose monitoring vs self-monitoring of blood glucose in distinct multi-ethnic cohorts of patients living with insulin-treated type 2 diabetes in the United States: A cost-utility analysis from a Medicare perspective
Hamza Alshannaq, Jessica Matuoka, Richard F Pollock, et al.
BMJ Open
|
July 2, 2017
Patient safety during procedural sedation using capnography monitoring: a systematic review and meta-analysis
Rhodri Saunders, Michel M R F Struys, Richard F Pollock, et al.
Scientific Reports
|
January 18, 2024
Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO<sub>2</sub> emissions in Sweden
Lars-Olaf Cardell, Thomas Sterner, Waqas Ahmed, et al.
Patient Related Outcome Measures
|
October 4, 2023
Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China
Shanlian Hu, Depei Wu, Jing Wu, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 21, 2018
Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States
Lars Wilkinson, Barnaby Hunt, Pierre Johansen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 15, 2022
Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts
Johannes Pöhlmann, Klas Bergenheim, Juan-Jose Garcia Sanchez, et al.
Annals of Hepatology
|
February 10, 2025
Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)
Zobair M Younossi, James M Paik, Linda Henry, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2026
Cost-effectiveness analysis of Dexcom ONE+ real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with type 2 diabetes in Aotearoa New Zealand
Ryan G Paul, Jessica Y Matuoka, Hamza A Alshannaq, et al.
Patient Related Outcome Measures
|
June 24, 2024
Systematic Literature Review of Studies Reporting Measures of Functional Outcome or Quality of Life in People with Negative Symptoms of Schizophrenia
Dusica Hadzi Boskovic, Jayne Smith-Palmer, Johannes Pöhlmann, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
June 17, 2024
Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden
Lars-Olaf Cardell, Thomas Sterner, Waqas Ahmed, et al.
Page
of 9